Business Wire

East Japan Railway Company: Releasing the Welcome Suica Mobile App for Overseas Visitors to Japan

24.3.2025 15:00:00 CET | Business Wire | Press release

Share

Travel Japan with a single app!

JR East has released the Welcome Suica Mobile app for overseas visitors to Japan on Thursday, March 6, 2025.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250310510899/en/

service banner

The app allows users to issue and top up their Suica in the app without going to a ticket office or vending machine at the station both before and after entering Japan; is accepted on trains, buses and other public transportation; and can even be used for shopping.

In fall 2025, the app will be connected to JR-EAST Train Reservation to enable the use of Shinkansen e-ticket and conventional line limited express ticketless service, with purchase of Green Car seats on local trains to be made available in spring 2026. Expanding services provide even more ways for our international visitors to enjoy seamless, ticketless transportation while in Japan.

1. App Release Date

Approx. 10:00 AM JST, Thursday, March 6, 2025 (tent.)

2. App Overview

Name: Welcome Suica Mobile
Language: English
Supported Devices: iPhone, Apple Watch
* Some iOS or watchOS versions may not be compatible.

Reference: Differences Between Welcome Suica Mobile and Welcome Suica (card)

 

Welcome Suica Mobile

Welcome Suica

Personalization

Non-personalized

Non-personalized

SF / e-money

Passes

Stored Fare (SF) refunds

×*

×*

Suica expiration date

180 days from issuance

28 days from first use

Topping up

  • Credit card registered to Apple Pay
  • Cash at ticket vending machine
  • Cash, etc., at ticket vending machine

Deposit

Not required

Not required

Legend: ✓: Supported ×: Not supported *Remaining balance is non-refundable. SF expires on Suica expiration date.

3. Key Features

Based on the service concept, “Travel Japan with a single app!”, Welcome Suica Mobile can be used for riding trains, buses and other public transportation, making purchases in stores that accept e-money, and even provides information for tourist attractions and transfer directions to support travel in Japan.
Official service website: https://www.jreast.co.jp/multi/wsmlp/

  • Images are for illustrative purposes only and are subject to change.
  • Apple, the Apple logo, Apple Pay, iPhone and Apple Watch are registered trademarks of Apple Inc. in the U.S. and other countries.
  • The iPhone trademark is used under license from Aiphone Co., Ltd.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250310510899/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SMBC and Toshiba Jointly Develop New Equity Indices Using Advanced Quantum-Driven Technologies28.5.2026 03:00:00 CEST | Press release

Sumitomo Mitsui Banking Corporation (“SMBC”) and Toshiba Corporation (“Toshiba”) today announced the joint development of the SMBC/TOSHIBA Quantum Driven Diversified Japan Equity Index and the SMBC/TOSHIBA Quantum Driven Diversified U.S. Equity Index, new equity indices realized with advanced quantum-driven technologies. Collectively, the indices are referred to as “SMBC/TOSHIBA Quantum Diversified” (the “Indices”). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519448161/en/ Toshiba’s Simulated Bifurcation Machine 1. Background and Objectives Equity investment is central to asset management, but it also carries the ever-present risk of abrupt and substantial market fluctuations driven by geopolitical developments, changes in economic policy, and other external factors. In uncertain markets, investors are constantly seeking innovations in risk diversification that can protect their assets from unexpected market shocks. SM

BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 202627.5.2026 23:00:00 CEST | Press release

TEVIMBRA plus ZIIHERA and chemotherapy demonstrated statistically significant overall survival benefit with an unprecedented seven-month improvement in first-line HER2+ GEAOral presentation at ASCO highlights benefit regardless of PD-L1 status, including in PD-L1 <1% BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that data from HERIZON-GEA-01 were published in The New England Journal of Medicine and will be presented in an oral presentation (Rapid Oral Abstract: 4010) at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2026, in Chicago.The HERIZON-GEA-01 clinical trial evaluated ZIIHERA® (zanidatamab) plus chemotherapy, with and without TEVIMBRA® (tislelizumab), compared with the control arm of trastuzumab plus chemotherapy as first-line treatment for advanced/metastatic HER2+ gastroesophageal adenocarcinoma (GEA). Dr. Sun Young Rha, Professor of Medical Oncology at the Yonsei Cancer Center, Yonsei Univ

Stallergenes Greer Foundation Celebrates Excellence in Allergy Innovation With 2025 Awards27.5.2026 17:22:00 CEST | Press release

The Stallergenes Greer Foundation, dedicated to advancing allergy research, fostering innovation and addressing environmental factors which impact allergies, is delighted to announce the recipients of the 2025 edition of its prestigious Science Awards for Allergy. Building on the success of the previous edition, this year’s awards recognise outstanding contributions to allergy research and patient engagement and allocate a total of €100,000 to support these initiatives. Four researchers have been selected by the Board as award recipients, each receiving €25,000 across two categories: Innovation In Treatment Awards Assoc. Professor Alexander Eggel, PhD, Department for Biomedical Research, University of Bern, and Department of Rheumatology and Immunology, University Hospital Bern, Switzerland, recognised for his research: “Improving diagnostic and therapeutic options for allergic patients”; Dr Janice A. Layhadi, PhD, Research Associate, National Heart and Lung Institute, Imperial College

Capchase Secures $200M+, as Demand for Vendor Financing in Enterprise Tech Deals Accelerates27.5.2026 16:00:00 CEST | Press release

As buyers face tighter budgets, Capchase helps technology companies close more deals faster with AI-enabled instant financing Capchase, the leading vendor financing platform for enterprise tech, today announced $200M+ in incremental funding to scale its embedded financing infrastructure globally and deploy more AI-enabled features. The funding, a mix of debt warehouse facilities and equity backed by institutional investors, reflects market validation that vendor financing has become essential infrastructure for enterprise technology companies to sell hardware and software products. As global B2B buyers face tighter budgets and greater scrutiny over large, up-front purchases, financing demand is growing. The Market Shift: Financing as a Growth Lever for B2B Tech Companies The $1.3 trillion vendor financing market has been traditionally dominated by banks and other lenders that utilize multi-thread email chains to manual doc review for underwriting. Capchase replaces those bottlenecks wi

ClickHouse Tops $250M ARR and 4,000 Customers, Launches Claude-Powered Agents at Open House 202627.5.2026 15:00:00 CEST | Press release

Annual run-rate revenue more than tripled year-over-year; new CostBench benchmark shows ClickHouse Cloud at 23x better cost-performance than the nearest cloud data warehouse ClickHouse today opened Open House 2026, its second annual user conference, with a set of announcements that mark one of the company's most active quarters since founding. ClickHouse’s serverless cloud offering has crossed over $250 million in annual run-rate revenue — more than triple a year ago — and added more than 1,000 net new customers since January, bringing its total to 4,000. To meet the demands of AI-era workloads, the company also launched ClickHouse Agents, a fully managed agentic analytics service powered by Anthropic's Claude; published CostBench, an open benchmark comparing the major cloud data warehouses on cost-performance; and introduced House Mates, its first formal partner program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260527

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye